BRIEF published on 11/01/2024 at 00:56, 22 days 8 hours ago Tikehau Capital Discloses Share Repurchase Activity Share Repurchase Market Abuse Regulation Stock Trading Financial Disclosure Tikehau Capital
PRESS RELEASE published on 11/01/2024 at 00:51, 22 days 8 hours ago Inside Information / Other news releases Tikehau Capital discloses shares repurchases in accordance with EU Regulation n° 596/2014. Detailed information available on their website Disclosure EU Regulation Market Abuse Tikehau Capital Shares Repurchases
BRIEF published on 10/24/2024 at 19:57, 29 days 13 hours ago Tikehau Capital Announces Share Repurchase Details Share Repurchase Stock Exchange Market Regulation Tikehau Capital Equity Management
PRESS RELEASE published on 10/24/2024 at 19:52, 29 days 13 hours ago Inside Information / Other news releases Tikehau Capital discloses shares repurchases from 18/10/2024 to 24/10/2024 as per EU Regulation n° 596/2014. Detailed info on their website EU Regulation Website Tikehau Capital Shares Repurchases Detailed Information
BRIEF published on 10/18/2024 at 11:25, 1 month 4 days ago Tikehau Capital Announces Share Repurchase Details for October 2024 Share Repurchase Stock Buyback Market Regulation Tikehau Capital October 2024
PRESS RELEASE published on 10/18/2024 at 11:20, 1 month 4 days ago Inside Information / Other news releases Tikehau Capital discloses shares repurchases according to EU Regulation 596/2014. Detailed information available on their website Stock Market EU Regulation 596/2014 Regulatory Information Tikehau Capital Shares Repurchases
BRIEF published on 10/11/2024 at 12:03, 1 month 11 days ago Tikehau Capital Discloses Share Repurchase Details Share Repurchase Market Abuse Regulation Tikehau Capital 2024 Transactions Paris Stock Exchange
PRESS RELEASE published on 10/11/2024 at 11:58, 1 month 11 days ago Inside Information / Other news releases Tikehau Capital discloses shares repurchases in compliance with EU Regulation n° 596/2014. Detailed information available on their website Market Abuse Regulation Compliance EU Regulation Tikehau Capital Shares Repurchases
BRIEF published on 10/04/2024 at 12:03, 1 month 18 days ago TIKEHAU CAPITAL: Status of Voting Rights as of September 30, 2024 Share Capital Voting Rights Actions General Meeting Tikehau Capital
PRESS RELEASE published on 10/04/2024 at 11:58, 1 month 18 days ago Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital Press release on total voting rights and shares as of 30 September 2024 under French commercial code and Financial Markets Authority regulations Voting Rights French Commercial Code Shares Financial Markets Authority 30 September 2024
Published on 11/22/2024 at 23:55, 9 hours 27 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 52 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 17 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 52 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 15 hours 7 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 28 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 26 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 21 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 14 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
